Donate
  • Freedom
  • Innovation
  • Growth

Merrill Matthews

Resident Scholar

Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.

Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted SuicideExpanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).  

He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times.  He was an award-winning political analyst for the USA Radio Network. 

Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.

August 16, 2022

The Democrats' Whatever-Tax-That-Can-Pass Approach

Responsible economists ask how a proposed tax increase could distort economic decisions; Democrats ask a different question.

August 16, 2022

Do Democrats See Us as a Nation of Tax Cheats?

The same people who have repeatedly claimed there is no election fraud think that large swaths of the public, especially high-income Americans and corporations, are not just avoiding taxes but cheating the government out of hundreds of billions of dollars in federal income tax obligations.

August 12, 2022

Let's Not Swim Upstream in Our Transition to Renewables

If transition advocates won’t acknowledge the problems we’ve experienced with renewables and provide balanced, logical and actionable solutions, we are right to question their motives and assertions of a smooth transition.

August 9, 2022

For Drug Companies, No Life-Saving Deed Goes Unpunished

We’ll never know what new drugs might have been developed but won’t be under the Democrats’ price controls.

August 2, 2022

Europe Faces the Russian Version of the Arab Oil Embargo

The EU is enduring the Russian version of the Arab oil embargo, in large part because it spurned multiple warnings over several years that Russia could and would use Europe’s energy dependence against 

August 2, 2022

How the EPA Could (Will?) Undermine Joe Manchin's Energy Concessions

Joe Manchin may have received Chuck Schumer's assurances that the Senate will vote on energy permitting reforms, but that doesn't mean the EPA will honor those reforms.

July 28, 2022

Democrats' Bad Drug Deal

It's understandable that Democrats want to accomplish something—anything—ahead of the midterm elections. But this plan won't just cost taxpayers and patients more money. It could cost them their lives.

July 26, 2022

Primaries Are Exposing the Lie of 'Voter Suppression'

Democrats and much of the media attacked states that passed election-integrity laws, making outrageous accusations. And yet it looks like voter turnout underperformed in the blue states making the accusations.

July 26, 2022

Dems Want to Make Drugs as Affordable as . . . Gasoline?

Democrats want to impose price controls on prescription drugs. But they haven't been able to lower the price of anything, including gasoline, so why would drugs be different?

July 19, 2022

Trump Shouldn't Run Again--Here Are 4 Reasons Why

While Democrats may be stuck with Biden, Republicans are not stuck with Trump. He may not be willing to move on with his life, but Republicans should be with theirs.

Total Records: 1735